Cargando…
ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms
ZEB1 and ZEB2 are structurally related E-box binding homeobox transcription factors that induce epithelial to mesenchymal transitions during development and disease. As such, they regulate cancer cell invasion, dissemination and metastasis of solid tumors. In addition, their expression is associated...
Autores principales: | Goossens, Steven, Wang, Jueqiong, Tremblay, Cedric S., De Medts, Jelle, T’Sas, Sara, Nguyen, Thao, Saw, Jesslyn, Haigh, Katharina, Curtis, David J., Van Vlierberghe, Pieter, Berx, Geert, Taghon, Tom, Haigh, Jody J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669144/ https://www.ncbi.nlm.nih.gov/pubmed/30679322 http://dx.doi.org/10.3324/haematol.2018.207837 |
Ejemplares similares
-
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling
por: Goossens, Steven, et al.
Publicado: (2015) -
Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity
por: Wang, Jueqiong, et al.
Publicado: (2021) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018) -
Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies
por: Pieters, Tim, et al.
Publicado: (2019) -
Myb drives B-cell neoplasms and myeloid malignancies in vivo
por: Pieters, Tim, et al.
Publicado: (2022)